Gene Therapy Market Size Worth $39.54 Million by 2026 | CAGR 19.1%: Grand View Research, Inc.

Monday, July 2, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, July 2, 2018 /PRNewswire/ --

The global gene therapy market size is expected to reach

USD 39.54 million by 2026. Rising competition among manufacturers and high number of molecules in pipeline are supporting the growth of the market.

     (Logo: )


therapy development is aimed to cure rare diseases and even some hereditary diseases, which are caused by a mutated or faulty gene. Moreover, ever-increasing need for new cures for orphan diseases and rising incidence of cancer caused due to mutations in genes are likely to stir up the demand for gene therapy.

As of early 2016, there were more than 1000 molecules in the pipeline in various clinical phases. However, around 76.0% of the molecules are in the developmental or preclinical stages and expected to hit the market in late 2020's.

A great number of large pharma/biotech players are estimated to acquire small firms as many have been trying to develop in-house expertise and build their own pipelines. This trend is anticipated to help the market gain tremendous traction over the coming years. Combination of gene therapy with small molecules or protein therapy is said to have lesser side effects and better efficacy as compared to gene therapy alone.

Cancer held the dominant share in the market in 2017 owing to relatively high adoption of gene therapies for cancer treatment. Continual rise in new cancer cases and related mortality per year triggers the need for development of robust treatment options. Ongoing developments in cancer gene studies have provided significant information about cancer-related molecular signatures, which in turn, is projected to support ongoing clinical trials for cancer therapeutics.

Browse full research report with TOC on "Gene Therapy Market Size, Share & Trends Analysis Report By Indication (Cancer, Genetic Disorders, Infectious Diseases, CVD, Neuro Disorders), By Vector Type (Viral, Non-Viral), By Region, and Segment Forecasts, 2018 - 2026" at:

Further Key Findings From the Report Suggest: 

  • More than 60.0% of the market is occupied by cancer research owing to a large pipeline.
  • Adenoviral vectors are the most used in pipeline development, closely followed by retroviral vectors.
  • Europe and the U.S. are poised to occupy the largest cumulative share in the market throughout the forecast period.
  • Asia Pacific is set to post noteworthy CAGR during the forecast period, owing to growing pipeline molecules and a large number of companies competing in the market.
  • Some of the key players in this market are UniQure N.V, Spark Therapeutics LLC, Bluebird Bio, Juno Therapeutics, GlaxoSmithKline, Celgene Corporation, Shire Plc, Sangamo Biosciences, Dimension Therapeutics, Voyager Therapeutics, Human Stem Cell Institute, Bristol Myer's Squibb, and Chiesi Farmaceutici S.p.A.

Browse related reports by Grand View Research: 

  • Virology Market - Public awareness programmers conducted worldwide on Flu, Zika virus, STDs, AIDS, and Ebola virus are also a key factor increasing public awareness and eventually influencing the market growth. 
  • Injectable Drug Delivery Market - The injectable drug delivery (IDD) market was estimated at USD 331.0 billion in 2015. 
  • Laboratory Filtration Market - The global laboratory filtration market was valued at USD 1.94 billion in 2015. 
  • Cell Surface Marker Detection Market - The Global cell surface marker detection market size was valued at USD 2.86 billion in 2014.

Grand View Research has segmented the global gene therapy market by indication, vector type, and region: 

  • Gene Therapy Indication Outlook (Revenue, USD Million, 2014 - 2026) 
    • Cancer
    • Cardio Vascular Diseases
    • Infectious Diseases
    • Genetic Disorders
    • Neuro Disorders
    • Others
  • Gene Therapy Vector Type Outlook (Revenue, USD Million, 2014 - 2026) 
    • Viral Vectors
      • Retrovirus
      • Adenovirus
      • Adeno-associated virus
      • Vaccinia virus
      • Herpes simplex virus
      • Others
    • Non-Viral Vectors
      • Injection of Naked DNA
      • Lipofection
      • Others
  • Gene Therapy Regional Outlook (Revenue, USD Million, 2014 - 2026) 
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
    • Asia Pacific
      • China
      • Japan
    • Latin America
      • Brazil
    • MEA
      • South Africa

Explore the BI enabled intuitive market research database, The Grand Library, by Grand View Research, Inc.

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store